ELAN
Price
$20.05
Change
-$0.28 (-1.38%)
Updated
Oct 9, 04:59 PM (EDT)
Capitalization
10.11B
26 days until earnings call
ZTS
Price
$143.37
Change
-$0.12 (-0.08%)
Updated
Oct 9, 04:59 PM (EDT)
Capitalization
63.55B
26 days until earnings call
Interact to see
Advertisement

ELAN vs ZTS

Header iconELAN vs ZTS Comparison
Open Charts ELAN vs ZTSBanner chart's image
Elanco Animal Health
Price$20.05
Change-$0.28 (-1.38%)
Volume$73.53K
Capitalization10.11B
ZOETIS
Price$143.37
Change-$0.12 (-0.08%)
Volume$27.58K
Capitalization63.55B
ELAN vs ZTS Comparison Chart in %
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. ZTS commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 10, 2025
Stock price -- (ELAN: $20.07 vs. ZTS: $143.39)
Brand notoriety: ELAN and ZTS are both notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 47% vs. ZTS: 123%
Market capitalization -- ELAN: $10.11B vs. ZTS: $63.55B
ELAN [@Pharmaceuticals: Generic] is valued at $10.11B. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $63.55B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whileZTS’s FA Score has 2 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • ZTS’s FA Score: 2 green, 3 red.
According to our system of comparison, ZTS is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 5 bullish TA indicator(s).

  • ELAN’s TA Score: 4 bullish, 4 bearish.
  • ZTS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ELAN and ZTS are a good buy in the short-term.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а -1.95% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was -2.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.65%. For the same industry, the average monthly price growth was +4.31%, and the average quarterly price growth was +62.17%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 05, 2025.

ZTS is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.65% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($63.5B) has a higher market cap than ELAN($10.1B). ZTS has higher P/E ratio than ELAN: ZTS (24.68) vs ELAN (22.81). ELAN YTD gains are higher at: 65.731 vs. ZTS (-11.071). ZTS has higher annual earnings (EBITDA): 4.02B vs. ELAN (1.45B). ZTS has more cash in the bank: 1.44B vs. ELAN (539M). ELAN has less debt than ZTS: ELAN (4.21B) vs ZTS (6.79B). ZTS has higher revenues than ELAN: ZTS (9.39B) vs ELAN (4.48B).
ELANZTSELAN / ZTS
Capitalization10.1B63.5B16%
EBITDA1.45B4.02B36%
Gain YTD65.731-11.071-594%
P/E Ratio22.8124.6892%
Revenue4.48B9.39B48%
Total Cash539M1.44B38%
Total Debt4.21B6.79B62%
FUNDAMENTALS RATINGS
ELAN vs ZTS: Fundamental Ratings
ELAN
ZTS
OUTLOOK RATING
1..100
1259
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7919
PRICE GROWTH RATING
1..100
3863
P/E GROWTH RATING
1..100
8785
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZTS's Valuation (33) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ELAN (94) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew somewhat faster than ELAN’s over the last 12 months.

ZTS's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew similarly to ELAN’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ELAN (79) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew somewhat faster than ELAN’s over the last 12 months.

ELAN's Price Growth Rating (38) in the Agricultural Commodities Or Milling industry is in the same range as ZTS (63) in the Pharmaceuticals Generic industry. This means that ELAN’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's P/E Growth Rating (85) in the Pharmaceuticals Generic industry is in the same range as ELAN (87) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANZTS
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 9 days ago
57%
Declines
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 3 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CEF38.570.77
+2.04%
Sprott Physical Gold and Silver Trust
FIIG21.270.08
+0.38%
First Trust Intermediate DurInvGrdCrpETF
MBSF25.520.03
+0.12%
Regan Floating Rate MBS ETF
RMOP25.000.01
+0.04%
Rockefeller Opportunistic Muncpl Bd ETF
RNRG33.15N/A
N/A
Global X Renewable Energy Producers ETF

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with VTRS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
-1.33%
VTRS - ELAN
54%
Loosely correlated
+0.20%
ZTS - ELAN
48%
Loosely correlated
-0.07%
PAHC - ELAN
39%
Loosely correlated
+0.16%
SNDL - ELAN
39%
Loosely correlated
+7.03%
AMRX - ELAN
38%
Loosely correlated
-1.81%
More